Skip to main content
SpringerLink
Log in

Management of Late-Life Depression

  • Chapter
  • First Online:
Antidepressants

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 250))

Abstract

Depression is a common disorder in late life that is associated with poor quality of life, increased disability, and increased all-cause mortality. Rates of completed suicide are the highest in older depressed men compared with any other age group. In this age group, depression is often concurrent with medical illness and it can aggravate the course of medical illness. Cognitive impairment is frequently present and may be the result of the depression itself or may be the consequence of a neurodegenerative disorder such as Alzheimer’s disease. Evidence-based psychotherapies, antidepressants, and somatic treatments such as electroconvulsive therapy are employed in the treatment of older depressed adults. Treatment may be complicated by the presence of cognitive impairment, other comorbid medical disorders, and medications used to treat these disorders. Certain safety issues such as increased bleeding risk, hyponatremia, decreased bone density and falls may be associated with antidepressant treatment, may be more common in older depressed adults, and their consequences may be more severe in late life. These risks, however, need to be weighed against the hazards of untreated depression. With appropriate care, most older depressed patients can be successfully treated and a positive outcome can have a significant effect on the patient’s quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T (1993) The course of geriatric depression with “reversible dementia”: a controlled study. Am J Psychiatry 150(11):1693–1699

    Article  CAS  PubMed  Google Scholar 

  • Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 54(10):915–922

    Article  CAS  PubMed  Google Scholar 

  • Anderson IM, Tomenson BM (1994) The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 8(4):238–249

    Article  CAS  PubMed  Google Scholar 

  • Bair MJ, Robinson RL, Eckert GJ, Stang PE, Croghan TW, Kroenke K (2004) Impact of pain on depression treatment response in primary care. Psychosom Med 66(1):17–22

    Article  PubMed  Google Scholar 

  • Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O’Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A (2011) Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 378(9789):403–411

    Article  CAS  PubMed  Google Scholar 

  • Bartoli F, Lillia N, Lax A, Crocamo C, Mantero V, Carrà G, Agostoni E, Clerici M (2013) Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat 2013:862978

    PubMed  PubMed Central  Google Scholar 

  • Blazer DG (2004) The epidemiology of depressive disorders in late life. In: Roose SP, Sackeim HA (eds) Late life depression. Oxford University Press, New York

    Google Scholar 

  • Bondareff W, Alpert M, Friedhoff AJ, Richter EM, Clary CM, Batzar E (2000) Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 157(5):729–736

    Article  CAS  PubMed  Google Scholar 

  • Brown PJ, Wall MM, Chen C, Levine ME, Yaffe K, Roose SP, Rutherford BR (2017) Biological age, not chronological age, is associated with late life depression. J Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glx162

    Article  CAS  Google Scholar 

  • Bruce ML, Leaf PJ, Rozal GP, Florio L, Hoff RA (1994a) Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am J Psychiatry 151:716–721

    Article  CAS  PubMed  Google Scholar 

  • Bruce ML, Seeman TE, Merrill SS, Blazer DG (1994b) The impact of depressive symptomatology on physical disability: MacArthur Studies of Successful Aging. Am J Public Health 84:1796–1799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bruce ML, Ten Have TR, Reynolds CF 3rd, Katz II, Schulberg HC, Mulsant BH, Brown GK, McAvay GJ, Pearson JL, Alexopoulos GS (2004) Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 291(9):1081–1091

    Article  CAS  PubMed  Google Scholar 

  • Brymer C, Winograd CH (1992) Fluoxetine in elderly patients: is there cause for concern? J Am Geriatr Soc 40(9):902–905

    Article  CAS  PubMed  Google Scholar 

  • Butters MA et al (2004) The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry 61(6):587–595

    Article  PubMed  Google Scholar 

  • Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW (2013) Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both. Br J Psychiatry 202(1):22–27

    Article  PubMed  Google Scholar 

  • Cutler NR, Zavadil AP 3rd, Eisdorfer C, Ross RJ, Potter WZ (1981) Concentrations of desipramine in elderly women. Am J Psychiatry 138(9):1235–1237

    Article  CAS  PubMed  Google Scholar 

  • de Abajo FJ (2011) Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging 28(5):345–367

    Article  PubMed  Google Scholar 

  • De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG (2014) Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics 55(6):536–547

    Article  PubMed  Google Scholar 

  • Devanand DP, Nobler MS, Cheng J, Turret N, Pelton GH, Roose SP, Sackeim HA (2005) Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder. Am J Geriatr Psychiatry 13(1):59–68

    Article  CAS  PubMed  Google Scholar 

  • Elgamal S, MacQueen G (2008) Galantamine as an adjunctive treatment in major depression. J Clin Psychopharmacol 28:357–359

    Article  PubMed  Google Scholar 

  • Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH (2008) Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165(3):342–351

    Article  PubMed  Google Scholar 

  • Fiaturi N, Greenblatt DJ (2018) Therapeutic drug monitoring of antidepressants. Handb Exp Pharmacol. https://doi.org/10.1007/164_2018_161

    Google Scholar 

  • Frasure-Smith N, Lespérance F, Talajic M (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA 270(15):1819–1825

    Article  CAS  PubMed  Google Scholar 

  • Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63(10):1121–1129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gandhi S, Shariff SZ, Al-Jaishi A, Reiss JP, Mamdani MM, Hackam DG, Li L, McArthur E, Weir MA, Garg AX (2017) Second-generation antidepressants and hyponatremia risk: a population-based cohort study of older adults. Am J Kidney Dis 69(1):87–96

    Article  CAS  PubMed  Google Scholar 

  • Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361(9358):653–661

    Article  CAS  PubMed  Google Scholar 

  • Georgotas A, McCue RE, Hapworth W, Friedman E, Kim OM, Welkowitz J, Chang I, Cooper TB (1986) Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychiatry 21(12):1155–1166

    Article  CAS  PubMed  Google Scholar 

  • Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR (2006) Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 63:283–288

    Article  PubMed  Google Scholar 

  • Golden C, Freshwater SM (2002) Stroop color and word test. Stoelting, Wood Dale

    Google Scholar 

  • Gonzales MM, Insel PS, Nelson C, Tosun D, Mattsson N, Mueller SG, Sacuiu S, Bickford D, Weiner MW, Mackin RS, Alzheimer’s Disease Neuroimaging Initiative (2017) Cortical atrophy is associated with accelerated cognitive decline in mild cognitive impairment with subsyndromal depression. Am J Geriatr Psychiatry 25(9):980–991

    Article  PubMed  Google Scholar 

  • Griebeler ML, Morey-Vargas OL, Brito JP et al (2014) Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med 161:639–649

    Article  PubMed  Google Scholar 

  • Hackam DG, Mrkobrada M (2012) Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 79(18):1862–1865

    Article  CAS  PubMed  Google Scholar 

  • Holzhemier PE et al (2008) A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. Int J Geriatr Psychiatry 23:625–631

    Article  Google Scholar 

  • Huang AX, Delucchi K, Dunn LB, Nelson JC (2015) A systematic review and meta-analysis of psychotherapy for late-life depression. Am J Geriatr Psychiatry 23:261–273

    Article  PubMed  Google Scholar 

  • Iosifescu DV, Nierenberg AA, Alpert JE, Smith M, Bitran S, Dording C, Fava M (2003) The impact of medical comorbidity on acute treatment in major depressive disorder. Am J Psychiatry 160(12):2122–2127

    Article  PubMed  Google Scholar 

  • Janowsky DS, el-Yousef MK, Davis JM (1974) Acetylcholine and depression. Psychosom Med 36(3):248–257

    Article  CAS  PubMed  Google Scholar 

  • Jiang HY, Chen HZ, Hu XJ, Yu ZH, Yang W, Deng M, Zhang YH, Ruan B (2015) Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 13(1):42–50

    Article  CAS  PubMed  Google Scholar 

  • Jiang HY, Xu LL, Li YC, Deng M, Peng CT, Ruan B (2016) Antidepressant use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis. J Psychiatr Res 83:160–167

    Article  PubMed  Google Scholar 

  • Jorge RE, Robinson RG, Arndt S, Starkstein S (2003) Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 160(10):1823–1829

    Article  PubMed  Google Scholar 

  • Jorge RE, Moser DJ, Acion L, Robinson RG (2008) Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 65(3):268–276

    Article  PubMed  Google Scholar 

  • Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG (2010) Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 67(2):187–196

    Article  PubMed  PubMed Central  Google Scholar 

  • Kaneriya SH, Robbins-Welty GA, Smagula SF, Karp JF, Butters MA, Lenze EJ, Mulsant BH, Blumberger D, Anderson SJ, Dew MA, Lotrich F, Aizenstein HJ, Diniz BS, Reynolds CF 3rd. (2016) Predictors and moderators of remission with aripiprazole augmentation in treatment-resistant late-life depression: an analysis of the IRL-GRey randomized clinical trial. JAMA Psychiat 73(4):329–336

    Article  Google Scholar 

  • Katona C, Hansen T, Olsen CK (2012) A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 27(4):215–223

    Article  PubMed  Google Scholar 

  • Katz IR, Simpson GM, Jethanandani V, Cooper T, Muhly C (1989) Steady state pharmacokinetics of nortriptyline in the frail elderly. Neuropsychopharmacology 2(3):229–236

    Article  CAS  PubMed  Google Scholar 

  • Katz IR, Simpson GM, Curlik SM, Parmelee PA, Muhly C (1990) Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry 51(Suppl):41–47

    PubMed  Google Scholar 

  • Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, Young RC, Sampson S, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Rosenquist PB, Raza A, Kaliora S, Latoussakis V, Tobias KG, Briggs MC, Liebman LS, Geduldig ET, Teklehaimanot AA, Lisanby SH, CORE/PRIDE Work Group (2016) Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study. Am J Psychiatry 173(11):1101–1109

    Article  PubMed  PubMed Central  Google Scholar 

  • Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey Replication (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095–3105

    Article  PubMed  Google Scholar 

  • Kindilien S, Goldberg EM, Roberts MH, Gonzales-Pacheco D (2018) Nutrition status, bone mass density, and selective serotonin reuptake inhibitors. Prev Med 113:62–67

    Article  PubMed  Google Scholar 

  • Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ (1993) Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 150(5):734–741

    Article  CAS  PubMed  Google Scholar 

  • Kok RM, Nolen WA, Heeren TJ (2012) Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 141(2–3):103–115

    Article  CAS  PubMed  Google Scholar 

  • Kvelde T, McVeigh C, Toson B, Greenaway M, Lord SR, Delbaere K, Close JC (2013) Depressive symptomatology as a risk factor for falls in older people: systematic review and meta-analysis. J Am Geriatr Soc 61(5):694–706

    Article  PubMed  Google Scholar 

  • Kvelde T, Lord SR, Close JC, Reppermund S, Kochan NA, Sachdev P, Brodaty H, Delbaere K (2015) Depressive symptoms increase fall risk in older people, independent of antidepressant use, and reduced executive and physical functioning. Arch Gerontol Geriatr 60(1):190–195

    Article  PubMed  Google Scholar 

  • Laghrissi-Thode F, Pollock BG, Miller M, Altieri L, Kupfer DJ (1995a) Comparative effects of sertraline and nortriptyline on body sway in older depressed patients. Am J Geriatr Psychiatry 3:217–228

    Article  PubMed  Google Scholar 

  • Laghrissi-Thode F, Pollock BG, Miller MC, Mulsant BH, Altieri L, Finkel MS (1995b) Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Psychopharmacol Bull 31:659–663

    CAS  PubMed  Google Scholar 

  • Larsson B, Mellström D, Johansson L, Nilsson AG, Lorentzon M, Sundh D (2018) Normal bone microstructure and density but worse physical function in older women treated with selective serotonin reuptake inhibitors, a cross-sectional population-based study. Calcif Tissue Int 103(3):278–288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee YC, Lin CH, Lin MS, Lu Y, Chang CH, Lin JW (2016) Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events. J Clin Psychiatry 77(1):e1–e7

    Article  PubMed  Google Scholar 

  • Lenze EJ, Mulsant BH, Blumberger DM, Karp JF, Newcomer JW, Anderson SJ, Dew MA, Butters MA, Stack JA, Begley AE, Reynolds CF 3rd. (2015) Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet 386(10011):2404–2412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC, CREATE Investigators (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297:367–379

    Article  PubMed  Google Scholar 

  • Leth-Møller KB, Hansen AH, Torstensson M, Andersen SE, Ødum L, Gislasson G, Torp-Pedersen C, Holm EA (2016) Antidepressants and the risk of hyponatremia: a Danish register-based population study. BMJ Open 6(5):e011200

    Article  PubMed  PubMed Central  Google Scholar 

  • Li X, Hamdy R, Sandborn W, Chi D, Dyer A (1996) Long-term effects of antidepressants on balance, equilibrium, and postural reflexes. Psychiatry Res 63(2–3):191–196

    Article  CAS  PubMed  Google Scholar 

  • Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351(9112):1303–1307

    Article  CAS  PubMed  Google Scholar 

  • Mackin RS, Areán PA (2005) Evidence-based psychotherapeutic interventions for geriatric depression. Psychiatr Clin North Am 28(4):805–820

    Article  PubMed  Google Scholar 

  • Mackin RS, Nelson JC, Delucchi KL, Raue PJ, Satre DD, Kiosses DN, Alexopoulos GS, Arean PA (2014) Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction. Am J Geriatr Psychiatry 22(12):1633–1641

    Article  PubMed  PubMed Central  Google Scholar 

  • Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS (2015) A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 40(8):2025–2037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mattis S (2004) Dementia rating scale-2: professional manual. Psychological Assessment Resources, Odessa

    Google Scholar 

  • McDonald WM (2016) Neuromodulation treatments for geriatric mood and cognitive disorders. Am J Geriatr Psychiatry 24:1130–1141

    Article  PubMed  Google Scholar 

  • Mead GE, Hsieh CF, Lee R, Kutlubaev M, Claxton A, Hankey GJ, Hackett M (2013) Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke 44(3):844–850

    Article  PubMed  Google Scholar 

  • Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, Papademetriou E, Leon AC, Heo M, STOP-PD Group (2009) A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry 66(8):838–847

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mittmann N, Herrmann N, Einarson TR et al (1997) The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 46:191–217

    Article  CAS  PubMed  Google Scholar 

  • Montgomery SA, Gommoll CP, Chen C, Greenberg WM (2015) Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials. CNS Spectr 20(2):148–156

    Article  PubMed  Google Scholar 

  • Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR (1993) Association of depression with 10-year poststroke mortality. Am J Psychiatry 150(1):124–129

    Article  CAS  PubMed  Google Scholar 

  • Myers JK, Weissman MM, Tischler GL, Holzer CE 3rd, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD Jr, Kramer M et al (1984) Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry 41(10):959–967

    Article  CAS  PubMed  Google Scholar 

  • National Center for Health Statistics, Data Brief No. 241 (2016). https://www.cdc.gov/nchs/products/databriefs/db241.htm

  • Nelson JC (2013) Use of adjunctive therapy in older depressed adults who are resistant to antidepressant treatment. In: Lavretsky H, Sajatovic M, Reynolds CF (eds) Late-life mood disorders. Oxford University Press, Oxford, pp 363–389

    Google Scholar 

  • Nelson JC (2016) Minor depression: is it important? How should it be treated? Am J Geriatr Psychiatry 24(8):624–626

    Article  PubMed  Google Scholar 

  • Nelson JC, Clary CM, Leon AC, Schneider LS (2005) Symptoms of late-life depression: frequency and change during treatment. Am J Geriatr Psychiatry 13(6):520–526

    Article  PubMed  Google Scholar 

  • Nelson JC, Devanand DP (2011) A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia. J Am Geriatr Soc 59(4):577–585

    Article  PubMed  Google Scholar 

  • Nelson JC, Jatlow P, Mazure C (1985) Desipramine plasma levels and response in elderly melancholics. J Clin Psychopharmacol 217:220

    Google Scholar 

  • Nelson JC, Mazure C, Attilasoy E, Jatlow PI (1988) Hydroxy desipramine in the elderly. J Clin Psychopharmacol 8:428–433

    Article  CAS  PubMed  Google Scholar 

  • Nelson JC, Mazure CM, Jatlow PI (1995) Desipramine treatment of major depression in patients over 75 years of age. J Clin Psychopharmacol 15:99–105

    Article  CAS  PubMed  Google Scholar 

  • Nelson JC, Delucchi K, Schneider LS (2008) Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry 16(7):558–567

    Article  PubMed  Google Scholar 

  • Nelson JC, Delucchi K, Schneider LS (2009) Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis. Int J Geriatr Psychiatry 24:539–544

    Article  PubMed  Google Scholar 

  • Nelson JC, Delucchi K, Schneider LS (2013) Moderators of outcome in late life depression: a patient-level meta-analysis. Am J Psychiatry 170:651–659

    Article  PubMed  Google Scholar 

  • Nelson JC, Spyker DA (2017) Morbidity and mortality associated with medications used in the treatment of depression: an analysis of cases reported to U.S. Poison Control Centers, 2000–2014. Am J Psychiatry 174(5):438–450

    Article  PubMed  Google Scholar 

  • Newhouse PA, Krishnan KR, Doraiswamy PM, Richter EM, Batzar ED, Clary CM (2000) A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 61(8):559–568

    Article  CAS  PubMed  Google Scholar 

  • O’Connor MK, Knapp R, Husain M, Rummans TA, Petrides G, Smith G, Mueller M, Snyder K, Bernstein H, Rush AJ, Fink M, Kellner C (2001) The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry 9(4):382–390

    Article  PubMed  Google Scholar 

  • Papakostas GI, Fava M (2009) Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 19(1):34–40

    Article  CAS  PubMed  Google Scholar 

  • Pelton GH, Andrews H, Roose SP, Marcus SM, D’Antonio K, Husn H, Petrella JR, Zannas AS, Doraiswamy PM, Devanand DP (2014) Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design. Contemp Clin Trials 37(2):200–208

    Article  PubMed  Google Scholar 

  • Pelton GH, Harper OL, Tabert MH, Sackeim HA, Scarmeas N, Roose SP, Devanand DP (2008) Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int J Geriatr Psychiatry 23(7):670–676

    Article  PubMed  PubMed Central  Google Scholar 

  • Pimontel MA et al (2016) A meta-analysis of executive dysfunction and antidepressant treatment response in late-life depression. Am J Geriatr Psychiatry 24(1):31–41

    Article  PubMed  Google Scholar 

  • Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association (2000) Am J Psychiatry 157(4 Suppl):1–45

    Google Scholar 

  • Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW (1996) Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 94:3123–3129

    Article  CAS  PubMed  Google Scholar 

  • Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA (1996) Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153(8):985–992

    Article  CAS  PubMed  Google Scholar 

  • Rapaport MH, Judd LL (1998) Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. J Affect Disord 48(2–3):227–232

    Article  CAS  PubMed  Google Scholar 

  • Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, Lenze EJ, Holm M, Rogers JC, Mazumdar S, Houck PR, Begley A, Anderson S, Karp JF, Miller MD, Whyte EM, Stack J, Gildengers A, Szanto K, Bensasi S, Kaufer DI, Kamboh MI, DeKosky ST (2011) Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 68(1):51–60

    Article  PubMed  PubMed Central  Google Scholar 

  • Reynolds CF 3rd, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ (2006) Maintenance treatment of major depression in old age. N Engl J Med. 354(11):1130–1138

    Article  CAS  PubMed  Google Scholar 

  • Robinson RG, Jorge RE (2016) Post-stroke depression: a review. Am J Psychiatry 173(3):221–231

    Article  PubMed  Google Scholar 

  • Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, Fonzetti P, Hegel M, Arndt S (2008) Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 299(20):2391–2400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Robinson M, Oakes TM, Raskin J, Liu P, Shoemaker S, Nelson JC (2014) Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo. Am J Geriatr Psychiatry 22(1):34–45

    Article  PubMed  Google Scholar 

  • Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H, Old-Old Depression Study Group (2004) Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 161(11):2050–2059

    Article  PubMed  Google Scholar 

  • Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL Lyketsos CG; DIADS-2 Research Group (2010). Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry 18(2):136–145

    Google Scholar 

  • Seppala LJ, Wermelink AMAT, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, van der Velde N, EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs (2018) Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc 19(4):371.e11–371.e17

    Article  Google Scholar 

  • Sheikh JI, Cassidy EL, Doraiswamy PM, Salomon RM, Hornig M, Holland PJ, Mandel FS, Clary CM, Burt T (2004) Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness. J Am Geriatr Soc 52(1):86–92

    Article  PubMed  Google Scholar 

  • Shin D, Oh YH, Eom CS, Park SM (2014) Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. J Neurol 261(4):686–695

    Article  CAS  PubMed  Google Scholar 

  • Sneed JR, Roose SP, Keilp JG, Krishnan KR, Alexopoulos GS, Sackeim HA (2007) Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry 15(7):553–563

    Article  PubMed  Google Scholar 

  • Steffens DC, Nelson JC, Eudicone JM, Andersson C, Yang H, Tran QV, Forbes RA, Carlson BX, Berman RM (2011) Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis. Int J Geriatr Psychiatry 26(6):564–572

    Article  PubMed  Google Scholar 

  • Stubbs B, Brefka S, Dallmeier D, Stubbs J, Vancampfort D, Denkinger MD (2016) Depression and reduced bone mineral density at the hip and lumbar spine: a comparative meta-analysis of studies in adults 60 years and older. Psychosom Med 78(4):492–500

    Article  PubMed  Google Scholar 

  • Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI (2011) Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry 72(12):1660–1668

    Article  CAS  PubMed  Google Scholar 

  • Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339(13):875–882

    Article  CAS  PubMed  Google Scholar 

  • von Moltke LL, Greenblatt DJ, Shader RI (1993) Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications. Clin Pharmacokinet 24(2):141–160

    Article  Google Scholar 

  • Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287(14):1840–1847

    Article  PubMed  Google Scholar 

  • Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J (1989) The functioning and well-being of depressed patients. Results from the medical outcomes study. JAMA 262(7):914–919

    Article  CAS  PubMed  Google Scholar 

  • Williams JW Jr, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, Cornell J, Sengupta A (2000) Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 284(12):1519–1526

    Article  CAS  PubMed  Google Scholar 

  • Wilson K, Mottram P, Sivanranthan A et al (2001) Antidepressant versus placebo for depressed elderly. Cochrane Database Syst Rev 2:CD000561

    Google Scholar 

  • Woodruff RA Jr, Guze WB, Clayton PJ (1971) Unipolar and bipolar primary affective disorder. Br J Psychiatry 119(548):33–38

    Article  PubMed  Google Scholar 

  • Young RC, Alexopoulos GS, Shamoian CA, Kent E, Dhar AK, Kutt H (1985) Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients. Am J Psychiatry 142(7):866–868

    Article  CAS  PubMed  Google Scholar 

  • Zhou C, Fang L, Chen Y, Zhong J, Wang H, Xie P (2018) Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis. Osteoporos Int 29(6):1243–1251

    Article  CAS  PubMed  Google Scholar 

  • Zilcha-Mano S, Roose SP, Brown PJ, Rutherford BR (2018) A machine learning approach to identifying placebo responders in late-life depression trials. Am J Geriatr Psychiatry 26(6):669–677

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leon J. Epstein Professor of Psychiatry, University of California San Francisco, San Francisco, CA, USA

    J. Craig Nelson

Authors
  1. J. Craig Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Craig Nelson .

Editor information

Editors and Affiliations

  1. School of Medicine-Wichita, University of Kansas, Wichita, KS, USA

    Matthew Macaluso

  2. School of Medicine-Wichita, University of Kansas, Wichita, KS, USA

    Sheldon H. Preskorn

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Craig Nelson, J. (2018). Management of Late-Life Depression. In: Macaluso, M., Preskorn, S. (eds) Antidepressants. Handbook of Experimental Pharmacology, vol 250. Springer, Cham. https://doi.org/10.1007/164_2018_170

Download citation

Publish with us

Policies and ethics

Search

Navigation